Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Show us examples of your corrective and preventive action (CAPA) processes and how they’ve been implemented.

Posted on August 9, 2023August 10, 2023 By digi

Corrective and Preventive Action (CAPA) processes are essential for addressing issues, preventing recurrence, and improving our quality management system. Here are examples of our CAPA processes and how they have been implemented:

Example 1: Corrective Action

  • Issue Identified: During an internal audit, it was found that a critical equipment calibration was overdue.
  • Root Cause Analysis: The root cause was determined to be a breakdown in the equipment maintenance scheduling process.
  • Corrective Action: A maintenance procedure review and update were initiated to prevent future delays in calibration. The overdue calibration was promptly performed.
  • Verification: After implementing the corrective action, a follow-up audit was conducted to ensure
the equipment calibration process was now on track.

Example 2: Preventive Action

  • Issue Identified: A quality trend analysis revealed a recurring pattern of minor deviations in a specific manufacturing process.
  • Root Cause Analysis: Investigation revealed that the deviations were caused by variations in raw material quality.
  • Preventive Action: A raw material quality monitoring program was established, including tighter specifications and increased supplier communication.
  • Implementation: The new raw material quality monitoring process was integrated into the manufacturing workflow, and suppliers were informed of the updated requirements.
  • Effectiveness Evaluation: Over the next several months, deviations related to the specific raw material decreased significantly, indicating the effectiveness of the preventive action.

Example 3: CAPA Review

  • Regular Review: Our CAPA process involves periodic review of past corrective and preventive actions to assess their ongoing effectiveness.
  • Continuous Improvement: During a review, it was noted that a previous corrective action implemented to address equipment downtime could be further optimized.
  • Enhancement: The procedure was updated to include additional preventive maintenance steps to reduce the risk of unexpected downtime.
  • Communication: The enhanced procedure was communicated to the maintenance team, and training was provided on the new steps.

These examples illustrate how our CAPA processes are applied to address issues, prevent recurrence, and drive continuous improvement. By diligently implementing CAPA processes, we ensure the quality, compliance, and efficiency of our operations in alignment with FDA regulations.

US FDA Mock Audits Tags:Audit process, Batch Record Review and Approval in GMP, Benefits of GMP Implementation, Cleaning and Sanitation in GMP Facilities, Compliance documentation, Contamination Prevention, Corrective actions, Deviations and Non-Conformities in GMP, Documentation Requirements in GMP, Equipment Calibration and Maintenance in GMP, GMP, GMP Enforcement and Monitoring, GMP guidelines, GMP Regulations, Good Manufacturing Practices (GMP), Inspection procedures, Internal audits, Manufacturing validation, Non-Compliance Consequences, Personnel Training in GMP, Pharmaceutical Industry, Preventive measures, Process Validation in GMP, Product Quality and Safety, Product quality assurance, Quality Control (QC) in GMP Compliance, Quality control procedures, Quality management system, Raw Materials Control in GMP, Regulatory communication, Regulatory compliance, Risk assessment, Specifications and Acceptance Criteria under GMP, Stability Studies in GMP, Storage and Distribution of Pharmaceutical Products under GMP, US FDA Audit

Post navigation

Previous Post: Provide examples of how you communicate with regulatory authorities, including the FDA, in the event of an audit or inspection.
Next Post: Explain your process for validating analytical methods used in quality control.

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Avoid Water Stagnation in GMP Drains and Sinks to Prevent Contamination

    Avoid Water Stagnation in GMP… Read more

Mock Audits

  • US FDA Mock Audits

US FDA Mock Audits

  • Can you provide an overview of your quality management system (QMS) and how it ensures compliance with FDA regulations?
  • How are employees trained on FDA regulations and guidelines relevant to their roles?
  • Can you demonstrate how your documentation practices ensure accuracy, traceability, and completeness?
  • How do you maintain and calibrate critical equipment used in your manufacturing process?
  • Show us your facility’s organization, cleanliness, and measures for preventing cross-contamination.
  • Explain your process for handling and documenting deviations from established procedures.
  • Provide examples of risk assessments you’ve conducted on your processes, products, and suppliers.
  • How do you manage and document changes to processes, equipment, or materials?
  • Walk us through your procedure for investigating and addressing customer complaints related to product quality.
  • Can you show us how you handle and document product recalls, if necessary?

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme